drugset

drugset / Trial / NCT00399230

A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

NCT00399230 ↗

Phase 4 Completed Innovative Medical

Non-randomizedSingle-groupOpen-label

Summary

To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Optive	Other / unclassified	—	—

Indications